Skip to content
Qvanteq
  • Home
  • Technology
    • Key benefits
    • Mechanism of Action
    • Publications
  • Products & Services
    • Neurovascular
    • Peripheral
    • Coronary
    • Other Devices
    • Consulting
  • About us
    • Management
    • Board of Directors
    • Quality system
    • Investors
  • News & Media
    • 2020
    • 2019
    • Archive
  • Contact
Qvanteq

Category: Archive

2018

In vitro testing capability with human blood

Posted on 8. October 20188. March 2019

In collaboration with academic institutions, Qvanteq has developed the capability for dynamic testing of any type of cardiovascular device in a blood loop model (Chandler Loop) using fresh whole human blood. This capability is also available for collaborations.

2018

Qvanteq AG ISO 13485 re-certified

Posted on 7. February 20187. February 2018

Qvanteq completed ISO13485 re-certification under the guidance of the notified body DEKRA.

2017

Financing round completed

Posted on 30. October 20177. February 2018

Qvanteq AG completed a financing round. It provides the company with sufficient cash to further develop its technology for vascular stents such as intracranial stents and flow diverters.

2017

Qvanteq’s technology in peer-reviewed journals

Posted on 7. April 20177. February 2018

In vivo data involving Qvanteq’s surface technology was published in the April issue of the journal Eurointervention.

2016

QUEST I FIM study completed

Posted on 25. September 20167. February 2018

Qvanteq AG today announced that its QUEST I study was completed. The technology has shown safety in humans.

Posts navigation

1 2 … 5 Next

Recent News

  • Stop the activation of the blood coagulation cascade by your medical device
  • Make any surface antithrombotic
  • Qvanteq is using MedtechVault
  • In-vitro thrombogenicity screening capacity
  • Qvanteq has moved to new offices

Qvanteq AG

Technoparkstr. 1, 8005 Zürich, Switzerland
+41 44 500 98 90
info@qvanteq.com

More

  • Meet us
  • Subscribe
  • Contact
  • Disclaimer
Copyright Qvanteq AG